Literature DB >> 24104552

Cooperative behavior of the nuclear receptor superfamily and its deregulation in prostate cancer.

Mark D Long1, James L Thorne, James Russell, Sebastiano Battaglia, Prashant K Singh, Lara E Sucheston-Campbell, Moray J Campbell.   

Abstract

The current study aimed to assess the topology of the nuclear receptor (NR) superfamily in normal prostate epithelial cells and its distortion in prostate cancer. Both in vitro and in silico approaches were utilized to profile NRs expressed in non-malignant RWPE-1 cells, which were subsequently investigated by treating cells with 132 binary NR ligand combinations. Nine significant cooperative interactions emerged including both superadditive [22(R)-hydroxycholesterol and eicosatetraenoic acid] and subadditive [1α,25(OH)2D3 and chenodeoxycholic acid] cellular responses, which could be explained in part by cooperative control of cell-cycle progression and candidate gene expression. In addition, publicly available data were employed to assess NR expression in human prostate tissue. Common and significant loss of NR superfamily expression was established in publicly available data from prostate tumors, in part predicting parallel distortion of targeting microRNA. These findings suggest that the NR superfamily in the prostate cooperatively integrates signals from dietary, hormonal and metabolic cues, and is significantly distorted in prostate cancer.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24104552      PMCID: PMC3908747          DOI: 10.1093/carcin/bgt334

Source DB:  PubMed          Journal:  Carcinogenesis        ISSN: 0143-3334            Impact factor:   4.944


  58 in total

Review 1.  Biological role of liver X receptors.

Authors:  M Baranowski
Journal:  J Physiol Pharmacol       Date:  2008-12       Impact factor: 3.011

2.  An essential role for nuclear receptors SXR/PXR in detoxification of cholestatic bile acids.

Authors:  W Xie; A Radominska-Pandya; Y Shi; C M Simon; M C Nelson; E S Ong; D J Waxman; R M Evans
Journal:  Proc Natl Acad Sci U S A       Date:  2001-03-13       Impact factor: 11.205

3.  Activators of the farnesoid X receptor negatively regulate androgen glucuronidation in human prostate cancer LNCAP cells.

Authors:  Jenny Kaeding; Emmanuel Bouchaert; Julie Bélanger; Patrick Caron; Sarah Chouinard; Mélanie Verreault; Olivier Larouche; Georges Pelletier; Bart Staels; Alain Bélanger; Olivier Barbier
Journal:  Biochem J       Date:  2008-03-01       Impact factor: 3.857

4.  Androgen deprivation by activating the liver X receptor.

Authors:  Jung Hoon Lee; Haibiao Gong; Shaheen Khadem; Yi Lu; Xiang Gao; Song Li; Jian Zhang; Wen Xie
Journal:  Endocrinology       Date:  2008-05-01       Impact factor: 4.736

5.  Bile acids as endogenous etiologic agents in gastrointestinal cancer.

Authors:  Harris Bernstein; Carol Bernstein; Claire M Payne; Katerina Dvorak
Journal:  World J Gastroenterol       Date:  2009-07-21       Impact factor: 5.742

Review 6.  Transcription factor co-repressors in cancer biology: roles and targeting.

Authors:  Sebastiano Battaglia; Orla Maguire; Moray J Campbell
Journal:  Int J Cancer       Date:  2010-06-01       Impact factor: 7.396

7.  Androgen receptor regulates a distinct transcription program in androgen-independent prostate cancer.

Authors:  Qianben Wang; Wei Li; Yong Zhang; Xin Yuan; Kexin Xu; Jindan Yu; Zhong Chen; Rameen Beroukhim; Hongyun Wang; Mathieu Lupien; Tao Wu; Meredith M Regan; Clifford A Meyer; Jason S Carroll; Arjun Kumar Manrai; Olli A Jänne; Steven P Balk; Rohit Mehra; Bo Han; Arul M Chinnaiyan; Mark A Rubin; Lawrence True; Michelangelo Fiorentino; Christopher Fiore; Massimo Loda; Philip W Kantoff; X Shirley Liu; Myles Brown
Journal:  Cell       Date:  2009-07-23       Impact factor: 41.582

8.  Elevated NCOR1 disrupts a network of dietary-sensing nuclear receptors in bladder cancer cells.

Authors:  S Asad Abedin; James L Thorne; Sebastiano Battaglia; Orla Maguire; Laura B Hornung; Alan P Doherty; Ian G Mills; Moray J Campbell
Journal:  Carcinogenesis       Date:  2009-01-06       Impact factor: 4.944

9.  Vitamin D and sunlight: strategies for cancer prevention and other health benefits.

Authors:  Michael F Holick
Journal:  Clin J Am Soc Nephrol       Date:  2008-06-11       Impact factor: 8.237

10.  Modulation of prostate cancer genetic risk by omega-3 and omega-6 fatty acids.

Authors:  Isabelle M Berquin; Younong Min; Ruping Wu; Jiansheng Wu; Donna Perry; J Mark Cline; Mike J Thomas; Todd Thornburg; George Kulik; Adrienne Smith; Iris J Edwards; Ralph D'Agostino; Hao Zhang; Hong Wu; Jing X Kang; Yong Q Chen
Journal:  J Clin Invest       Date:  2007-07       Impact factor: 14.808

View more
  10 in total

Review 1.  Vitamin D receptor and RXR in the post-genomic era.

Authors:  Mark D Long; Lara E Sucheston-Campbell; Moray J Campbell
Journal:  J Cell Physiol       Date:  2015-04       Impact factor: 6.384

Review 2.  Nuclear receptors in cancer - uncovering new and evolving roles through genomic analysis.

Authors:  Vineet K Dhiman; Michael J Bolt; Kevin P White
Journal:  Nat Rev Genet       Date:  2017-12-27       Impact factor: 53.242

3.  Nuclear Receptors and Lipid Sensing.

Authors:  James L Thorne; Giorgia Cioccoloni
Journal:  Adv Exp Med Biol       Date:  2022       Impact factor: 3.650

4.  VDR regulation of microRNA differs across prostate cell models suggesting extremely flexible control of transcription.

Authors:  Prashant K Singh; Mark D Long; Sebastiano Battaglia; Qiang Hu; Song Liu; Lara E Sucheston-Campbell; Moray J Campbell
Journal:  Epigenetics       Date:  2015-01-29       Impact factor: 4.528

5.  Pan-cancer analyses of the nuclear receptor superfamily.

Authors:  Mark D Long; Moray J Campbell
Journal:  Nucl Receptor Res       Date:  2015-12-15

6.  Integration of VDR genome wide binding and GWAS genetic variation data reveals co-occurrence of VDR and NF-κB binding that is linked to immune phenotypes.

Authors:  Prashant K Singh; Patrick R van den Berg; Mark D Long; Angie Vreugdenhil; Laurie Grieshober; Heather M Ochs-Balcom; Jianmin Wang; Sylvie Delcambre; Sami Heikkinen; Carsten Carlberg; Moray J Campbell; Lara E Sucheston-Campbell
Journal:  BMC Genomics       Date:  2017-02-06       Impact factor: 3.969

Review 7.  The Role of Nuclear Receptors in Prostate Cancer.

Authors:  Masaki Shiota; Naohiro Fujimoto; Eiji Kashiwagi; Masatoshi Eto
Journal:  Cells       Date:  2019-06-17       Impact factor: 6.600

8.  ER-Negative Breast Cancer Is Highly Responsive to Cholesterol Metabolite Signalling.

Authors:  Samantha A Hutchinson; Priscilia Lianto; Hanne Roberg-Larsen; Sebastiano Battaglia; Thomas A Hughes; James L Thorne
Journal:  Nutrients       Date:  2019-11-01       Impact factor: 5.717

9.  Cis-regulatory elements in conserved non-coding sequences of nuclear receptor genes indicate for crosstalk between endocrine systems.

Authors:  Maria Araceli Diaz Cruz; Dan Lund; Ferenc Szekeres; Sandra Karlsson; Maria Faresjö; Dennis Larsson
Journal:  Open Med (Wars)       Date:  2021-04-12

Review 10.  Nuclear receptors and the Warburg effect in cancer.

Authors:  James L Thorne; Moray J Campbell
Journal:  Int J Cancer       Date:  2014-06-16       Impact factor: 7.396

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.